Study Information
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
To examine the following:
(1) Cardiovascular disease (CVD) prevalence among Asians, Pacific Islander, and mixed-race Asian-Pacific Islander subpopulations.
(2) Demographic, clinical, and psychosocial factors to explain observed differences in CVD prevalence.
(3) Prevalence of secondary CVD outcomes and quality of life; demographic, clinical, and psychosocial factors explaining observed differences.
PI is Beth Waitzfelder, Ph.D., Center for Health Research at Kaiser Permanente Hawaii.
Co-PIs are (1) Stephen P. Fortmann, M.D., Kaiser Permanente Center for Health Research and Stanford School of Medicine, as well as (2) Latha Palaniappan, M.D., M.S., Stanford School of Medicine.
Site PI and Co-Investigator is Sukyung Chung, Ph.D.
Principal Investigator
External PI, Principal Investigator
Co-Investigator(s)
Funder
National Heart, Lung, and Blood Institute
Related Studies
COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs
Investigators: Cheryl Stults, Ph.D., Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH
Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women
Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator
Prevalence, Treatment and Outcomes of Asian Subgroups with Coronary Artery Disease in the U.S.
Investigators: Jiang Li, Ph.D., MPH, External PI, Principal Investigator